Merck sees promising results in trial of COVID-19 pill, will apply for emergency approval from FDA

Posted on AllSides October 1st, 2021
From The Right
Merck & Co. via AP

Merck on Friday said it will seek emergency approval of an antiviral pill to treat COVID-19 after it significantly cut the risk of bad outcomes in clinical trials.

The New Jersey-based drugmaker said the drug, molnupiravir, cut the risk of hospitalization or death in half in high-risk patients with mild to moderate illness.

If authorized for use, it would be a groundbreaking treatment. Pills are easy to take and can reach a wider audience than monoclonal antibodies, an effective treatment in high demand.

Merck said it stopped the trial early in consultation...

Read full story
Some content from this outlet may be limited or behind a paywall.

Washington Times

AllSides Media Bias Rating: Lean Right
AllSides Media Bias Rating: Lean Right
106712/84319
See full bias rating for Washington Times
Learn about media bias
https://www.washingtontimes.com/news/2021/oct/1/merck-says-experimental-pill-cuts-worst-effects-of/

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right